Squarepoint Ops »

Monte Rosa Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2023-12-31 $99k 18k 5.65
2023-03-31 $109k 14k 7.79
2022-09-30 $232k 28k 8.17
2022-06-30 $148k 15k 9.67
2021-06-30 $640k 28k 22.69

More positions owned by Squarepoint Ops

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Amazon Call Option (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
Royal Caribbean Cruises (RCL)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Squarepoint Ops

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Casdin Capital
Caption Management
Charles Schwab Investment Management
TD Asset Management
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Bank of America Corporation

View all funds holding Monte Rosa Therapeutics